Robert C. Hood

Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target Clinical Trial

Robert C. Hood, Richard F. Arakaki, Carol Wysham et al. · Endocrine Practice · 2015 · 60 citations

Medicine, Endocrinology, Pharmacotherapy +14

Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients

M. Schütt, A Zimmermann, Robert C. Hood et al. · Experimental and Clinical Endocrinology & Diabetes · 2015 · 40 citations

Medicine, Endocrinology, Pharmacotherapy +17

Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis

Elizabeth L. Eby, Ping Wang, Bradley Curtis et al. · Journal of Medical Economics · 2013 · 31 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Healthcare Costs and Adherence Associated with Human Regular U-500 Versus High-Dose U-100 Insulin in Patients with Diabets

Elizabeth L. Eby, Anthony J. Zagar, Ping Wang et al. · Endocrine Practice · 2014 · 28 citations

Medicine, Endocrinology, Pharmacoeconomics +13

A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection

Robert C. Hood, Kenneth M. Shermock, Charles Emerman · The American Journal of Emergency Medicine · 2004 · 28 citations

Medicine, Pharmacotherapy, Surgery +15